SONTRA MEDICAL CORP 4
4 · SONTRA MEDICAL CORP · Filed Sep 17, 2007
Insider Transaction Report
Form 4
SONTRA MEDICAL CORPSONT.OB
MOONEY PATRICK T
DirectorCEO and President
Transactions
- Award
Common Stock
2007-09-14+625,907→ 625,907 total - Award
Employee Stock Option (right to buy)
2007-09-14+500,000→ 500,000 totalExercise: $2.39Exp: 2017-09-14→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]Received in exchange for 1,436,885 shares of common stock of Durham Pharmaceuticals Ltd. (d/b/a Echo Therapeutics, Inc.) ("Echo") in connection with the merger (the "Merger") of Echo with and into a wholly-owned subsidiary of Sontra Medical Corp. (the "Company"). On the effective date of the Merger, the closing price of the common stock of the Company was $2.39 per share. In connection with the Merger, each outstanding share of Echo common stock was cancelled, extinguished, and converted automatically into the right to receive 0.4356 shares of the Company's common stock.
- [F2]The option vests in three equal annual installments beginning on September 14, 2007.